Search

everythinglearnresearchcommunity

for

Search:↓

Chronic cutaneous lupus erythematosus should be considered when acne treatments don't work.

Four drugs were found that could potentially treat COVID-19 by inhibiting the virus in lab tests.

Frontal Fibrosing Alopecia may be linked to autoimmune diseases like Sjögren's syndrome.

A woman with lupus improved significantly from scalp hair loss after treatment, highlighting the need to identify psoriatic alopecia in lupus patients to avoid permanent hair loss.

The document concludes that doctors should check for frontal fibrosing alopecia in patients with acquired hyperpigmentation and that early treatment is important.

A woman with discoid lupus improved with treatment after being misdiagnosed with a different hair loss condition.

Frontal Fibrosing Alopecia is a slowly progressing hair loss condition, likely underdiagnosed, with ineffective treatments, needing more research to understand it fully.

The conclusion is that having both Frontal Fibrosing Alopecia and Discoid Lupus Erythematosus may suggest a shared immune response in certain people, and a mix of antimalarial drugs and 5-alfa-reductase inhibitors is recommended for treatment.

HSD11b1 affects skin nerves and increases non-histaminergic itch.

Autophagy, a cell recycling process, is crucial for prolonged hair growth and could be a potential target for treating hair growth disorders.

Spironolactone helped reduce excessive facial hair in a woman with porphyria cutanea tarda.

The document concludes that drug repurposing, which is reusing known medicines for new illnesses, can provide faster, cheaper treatment options for various serious diseases, including cancer, COVID-19, and rare diseases.

Antigen presenting cells around hair follicles are crucial in SLE-related hair loss.

A woman was diagnosed with porphyria cutanea tarda and improved with phlebotomy and lifestyle changes.

Chronic cutaneous lupus erythematosus causes scarring, hair loss, and skin discoloration, especially on sun-exposed areas.

Low-Level Light Therapy significantly reduced inflammation and promoted hair regrowth in patients with Lichen planopilaris.

Hair transplantation may not work for Frontal Fibrosing Alopecia as transplanted hair was lost when the disease came back.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

Two patients with porphyria cutanea tarda experienced their grey hair turning dark again.

Dilated follicular infundibula and increased catagen/telogen follicles are key indicators for diagnosing alopecia areata.

Treatment with dutasteride, minoxidil, and artificial hair transplantation improved appearance but caused folliculitis.

Saw palmetto causes allergic reaction, minoxidil causes skin irritation; use cautiously for hair loss.

Thalidomide works best for skin lupus not helped by antimalarials, but has many side effects; other treatments are less effective, especially if patients also have systemic lupus.

Hair graying is influenced by factors like nerves, fat cells, and immune cells, not just hair follicles.

A woman with complete hair loss and severe hyperthyroidism was successfully treated with azathioprine and hydroxychloroquine.

Hydroxychloroquine effectively treated twenty-nail dystrophy in a patient with alopecia areata.

Heptaminol may cause hair lightening in hemodialysis patients.

The conclusion is that differentiating wound types in RDEB patients is important for clinical trials and understanding the disease.

SLE patients need careful diagnosis to distinguish infections from disease flares for proper treatment.

Tofacitinib may slow hair loss in scarring alopecias but is unlikely to regrow significant hair.